TAC1 and osteosarcoma: Despite these limitations, the study reveals a previously unrecognized post‐transcriptional regulatory mechanism by which LncDARS‐AS1 stabilizes ATP1A1 and enhances Na+/K+‐ATPase (NKA) activity, ultimately promoting osteosarcoma progression.